Phreesia, Inc. PHR
Phreesia, Inc. (PHR) earns a Piotroski F-score of 5/9 (mixed financial health), with an Altman Z″ in the distress zone. It does not currently pay a dividend. FY2026 revenue was $480.6M at a 0.5% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Analyst price target
Wall Street analyst consensus — a sentiment gauge, not our scoring.
Smart money · insiders, last 12 months
Open-market insider purchases minus sells (SEC Form 4) — real buying with their own money is a bullish “smart money” signal; grants and option exercises are excluded.
How it ranks in Services · percentile among 982 companies
Percentile vs other Services companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 5/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · distress zone
| Component | Value |
|---|---|
| Working capital / assets | 0.146 |
| Retained earnings / assets | -1.204 |
| EBIT / assets | -0.01 |
| Equity / liabilities | 1.033 |
Sector peers · similar-size Services companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| PHR | Phreesia, Inc. | 5/9 | -1.95 | 269.9 | +14.5% |
| LQDT | LIQUIDITY SERVICES INC | 6/9 | 3.31 | 43.4 | +31.2% |
| EEX | Emerald Holding, Inc. | 4/9 | -1.59 | — | +16.2% |
| UXIN | Uxin Ltd | 3/9 | — | — | +143.3% |
| SEZL | Sezzle Inc. | 7/9 | 8.04 | 43.1 | +66.1% |
| FVRR | Fiverr International Ltd. | 7/9 | 2 | 19.1 | +10.1% |
| ICTSF | ICTS INTERNATIONAL N V | 2/9 | 0.59 | — | +10.6% |
About Phreesia, Inc.
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. It offers solutions including appointment optimization and referral management using AI-enabled workflows; and AI-based smart answering solution patient communications supported by voice and messaging solutions; integrated payment solutions embedded in intake and post-visit workflows, and financing solutions that enable healthcare organizations to accelerate cash collections while offering flexible payment options to patients; and digital intake and clinical data capture, patient engagement and activation tools, and measurement and analytics solutions. It also offers PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, which are on-site kiosks. The company serves a range of healthcare organizations including ambulatory practices, health systems, and hospitals, as well as life sciences companies, government entities, patient advocacy, public interest and not-for-profit and other organizations. Phreesia, Inc. was incorporated in 2005 and is based in Wilmington, Delaware.
FAQ
Is PHR financially healthy?
Phreesia, Inc.'s Piotroski F-score is 5/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the distress zone.
Does PHR pay a dividend?
No, Phreesia, Inc. does not currently pay a dividend.
How profitable is PHR?
In FY2026, Phreesia, Inc. had a net margin of 0.5% and a return on equity of 0.7%.
What is PHR's P/E ratio?
Phreesia, Inc.'s trailing price-to-earnings (P/E) ratio is about 269.9×, based on its latest annual earnings.
What is the analyst price target for PHR?
The average Wall-Street price target for Phreesia, Inc. is $13.94, about 13.7% above the recent price, from 17 analysts (consensus: buy).
Is PHR a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on Phreesia, Inc.: a Piotroski F-score of 5/9, an Altman Z″ in the distress zone, a P/E of about 269.9×. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2026-01-31. Facts plus Stocktoria's own computed scores — not investment advice.